Cargando…
Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer
OBJECTIVE: Bladder cancer contributes to a serious disease burden in clinical settings. The characteristics and prognosis of patients with muscle-invasive bladder cancer (MIBC) and non-muscle-invasive bladder cancer (NMIBC) are distinctly different. The study aims to figure out the respective role o...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627284/ https://www.ncbi.nlm.nih.gov/pubmed/34849009 http://dx.doi.org/10.2147/IJGM.S339996 |
_version_ | 1784606821696143360 |
---|---|
author | Zhang, Shun Wang, Cheng Xia, Weimin Duan, Huangqi Qian, Subo Shen, Haibo |
author_facet | Zhang, Shun Wang, Cheng Xia, Weimin Duan, Huangqi Qian, Subo Shen, Haibo |
author_sort | Zhang, Shun |
collection | PubMed |
description | OBJECTIVE: Bladder cancer contributes to a serious disease burden in clinical settings. The characteristics and prognosis of patients with muscle-invasive bladder cancer (MIBC) and non-muscle-invasive bladder cancer (NMIBC) are distinctly different. The study aims to figure out the respective role of ferroptosis in MIBC and NMIBC and to construct ferroptosis-related gene signatures that could predict patients’ prognoses. METHODS: A total of 608 MIBC and 414 NMIBC RNA-seq transcriptome data with intact clinical and follow-up information were downloaded from The Cancer Genome Atlas (TCGA), ArrayExpress, and Gene expression omnibus (GEO) database. Ferroptosis-related multigene prognostic models were constructed and externally validated, respectively, in MIBC and NMIBC. Further functional enrichment analyses were also performed to explicate the underlying mechanisms and the differences between the two bladder cancer subtypes. RESULTS: In MIBC, a 7-gene signature for prognostic prediction was constructed. Patients were then divided into high-risk and low-risk groups according to the risk scores calculated by the 7-gene prognostic model. Patients in the high-risk group presented an impaired OS when compared with patients in the low-risk group both in the training cohort and validation cohort. Further functional analyses revealed distinctly different immune statuses between the two risk-stratification groups, speculating that exhausted immune cell function was a cause of the worst OS in the high-risk group. In NMIBC, 6 ferroptosis-related genes were identified that were significantly correlated with recurrence-free survival (RFS). Similarly, a 6-gene prognostic model was constructed and verified as an independent prognostic predictor for RFS. Functional analyses revealed significant differences in the expressions of nuclear division genes between the high-risk group and low-risk group. CONCLUSION: Two novel ferroptosis-related multigene prognostic models for, respectively, predicting OS in MIBC and RFS in NMIBC were identified in this study, which indicated ferroptosis played vital roles in the oncogenesis and development of MIBC and NMIBC. |
format | Online Article Text |
id | pubmed-8627284 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-86272842021-11-29 Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer Zhang, Shun Wang, Cheng Xia, Weimin Duan, Huangqi Qian, Subo Shen, Haibo Int J Gen Med Original Research OBJECTIVE: Bladder cancer contributes to a serious disease burden in clinical settings. The characteristics and prognosis of patients with muscle-invasive bladder cancer (MIBC) and non-muscle-invasive bladder cancer (NMIBC) are distinctly different. The study aims to figure out the respective role of ferroptosis in MIBC and NMIBC and to construct ferroptosis-related gene signatures that could predict patients’ prognoses. METHODS: A total of 608 MIBC and 414 NMIBC RNA-seq transcriptome data with intact clinical and follow-up information were downloaded from The Cancer Genome Atlas (TCGA), ArrayExpress, and Gene expression omnibus (GEO) database. Ferroptosis-related multigene prognostic models were constructed and externally validated, respectively, in MIBC and NMIBC. Further functional enrichment analyses were also performed to explicate the underlying mechanisms and the differences between the two bladder cancer subtypes. RESULTS: In MIBC, a 7-gene signature for prognostic prediction was constructed. Patients were then divided into high-risk and low-risk groups according to the risk scores calculated by the 7-gene prognostic model. Patients in the high-risk group presented an impaired OS when compared with patients in the low-risk group both in the training cohort and validation cohort. Further functional analyses revealed distinctly different immune statuses between the two risk-stratification groups, speculating that exhausted immune cell function was a cause of the worst OS in the high-risk group. In NMIBC, 6 ferroptosis-related genes were identified that were significantly correlated with recurrence-free survival (RFS). Similarly, a 6-gene prognostic model was constructed and verified as an independent prognostic predictor for RFS. Functional analyses revealed significant differences in the expressions of nuclear division genes between the high-risk group and low-risk group. CONCLUSION: Two novel ferroptosis-related multigene prognostic models for, respectively, predicting OS in MIBC and RFS in NMIBC were identified in this study, which indicated ferroptosis played vital roles in the oncogenesis and development of MIBC and NMIBC. Dove 2021-11-23 /pmc/articles/PMC8627284/ /pubmed/34849009 http://dx.doi.org/10.2147/IJGM.S339996 Text en © 2021 Zhang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Zhang, Shun Wang, Cheng Xia, Weimin Duan, Huangqi Qian, Subo Shen, Haibo Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer |
title | Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer |
title_full | Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer |
title_fullStr | Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer |
title_full_unstemmed | Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer |
title_short | Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer |
title_sort | novel ferroptosis-related multigene prognostic models for patients with bladder cancer |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627284/ https://www.ncbi.nlm.nih.gov/pubmed/34849009 http://dx.doi.org/10.2147/IJGM.S339996 |
work_keys_str_mv | AT zhangshun novelferroptosisrelatedmultigeneprognosticmodelsforpatientswithbladdercancer AT wangcheng novelferroptosisrelatedmultigeneprognosticmodelsforpatientswithbladdercancer AT xiaweimin novelferroptosisrelatedmultigeneprognosticmodelsforpatientswithbladdercancer AT duanhuangqi novelferroptosisrelatedmultigeneprognosticmodelsforpatientswithbladdercancer AT qiansubo novelferroptosisrelatedmultigeneprognosticmodelsforpatientswithbladdercancer AT shenhaibo novelferroptosisrelatedmultigeneprognosticmodelsforpatientswithbladdercancer |